Publication:
Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy

Simple item page
dc.contributor.authorZHAO, Jiacheng
dc.contributor.authorBABIUCH, Krzysztof
dc.contributor.authorLu, Hongxu
dc.contributor.authorDag, AYDAN
dc.contributor.authorGOTTSCHALDT, Michael
dc.contributor.authorSTENZEL, Martina H.
dc.contributor.institutionauthorDAĞ, AYDAN
dc.date.accessioned2019-10-05T15:14:54Z
dc.date.available2019-10-05T15:14:54Z
dc.date.issued2014-01-01
dc.description.abstractFructose transporter GLUT5 is overexpressed in breast cancer cell lines, but not in healthy tissue. Micelles based on fructose, which were found to be low fouling, showed a high uptake by breast cancer cells (MCF-7 and MDA-MB-231 cells), but only negligible uptake by macrophages.
dc.description.sponsorshipTürkiye Bilimsel Ve Teknolojik Araştırma Kurumu ( Tübitak )
dc.identifier10.1177/0748233709346755
dc.identifier.citationZHAO J., BABIUCH K., Lu H., Dag A., GOTTSCHALDT M., STENZEL M. H. , -Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy-, CHEMICAL COMMUNICATIONS, cilt.50, ss.15928-15931, 2014
dc.identifier.urihttps://hdl.handle.net/20.500.12645/5798
dc.language.isoen
dc.titleFructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameToxicology and industrial health
local.avesis.id8f57ec83-a133-4342-ad4b-ae861748cf79
local.avesis.response5668
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
relation.isAuthorOfPublication5053fdfd-57cd-423a-9076-db4bab8cbe3d
relation.isAuthorOfPublication.latestForDiscovery5053fdfd-57cd-423a-9076-db4bab8cbe3d
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Silinecekler